Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dodekin by Philogen for Melanoma: Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs...
Dodekin by Philogen for Non-Small Cell Lung Cancer: Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Dodekin by Philogen for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...